Tuesday, August 6, 2019

Granules India#39;s arm gets USFDA nod for Amphetamine Sulfate tablets

Granules India#39;s arm gets USFDA nod for Amphetamine Sulfate tablets The US Food Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company#39;s subsidiary, Granules Pharmaceuticals Inc, for Amphetamine Sulfate tablets USP 5 mg and 10 mg, Granules India said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2YxEs5a
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...